Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Weekly News Recap #Phispers
1. Bms 742413
2. Bms-742413
3. N-(3-(7-methyl-1h-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl))-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide
1. Vazegepant
2. Bms-742413
3. Bhv-3500
4. Zavegepant [usan]
5. Odu3zaz94j
6. Bms-742413-01
7. 1337918-83-8
8. Chembl2397415
9. N-[(2r)-3-(7-methyl-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-1h-quinolin-3-yl)piperidine-1-carboxamide
10. 1-piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-n-((1r)-1-((7-methyl-1h-indazol-5-yl)methyl)-2-(4-(1-methyl-4-piperidinyl)-1-piperazinyl)-2-oxoethyl)-
11. 4-(1,2-dihydro-2-oxo-3-quinolinyl)-n-((1r)-1-((7-methyl-1h-indazol-5-yl)methyl)-2-(4-(1-methyl-4-piperidinyl)-1-piperazinyl)-2-oxoethyl)-1-piperidinecarboxamide
12. Zavegepant [inn]
13. Unii-odu3zaz94j
14. Vazegepant [who-dd]
15. Schembl107428
16. Gtpl11513
17. Ex-a6698
18. Bdbm50436107
19. Bms742413
20. Who 11512
21. Hy-134992
22. Cs-0168642
Molecular Weight | 638.8 g/mol |
---|---|
Molecular Formula | C36H46N8O3 |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 638.36928736 g/mol |
Monoisotopic Mass | 638.36928736 g/mol |
Topological Polar Surface Area | 117 Ų |
Heavy Atom Count | 47 |
Formal Charge | 0 |
Complexity | 1160 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
85
PharmaCompass offers a list of Vazegepant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vazegepant manufacturer or Vazegepant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vazegepant manufacturer or Vazegepant supplier.
PharmaCompass also assists you with knowing the Vazegepant API Price utilized in the formulation of products. Vazegepant API Price is not always fixed or binding as the Vazegepant Price is obtained through a variety of data sources. The Vazegepant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zavegepant HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zavegepant HCl, including repackagers and relabelers. The FDA regulates Zavegepant HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zavegepant HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zavegepant HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zavegepant HCl supplier is an individual or a company that provides Zavegepant HCl active pharmaceutical ingredient (API) or Zavegepant HCl finished formulations upon request. The Zavegepant HCl suppliers may include Zavegepant HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Zavegepant HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zavegepant HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zavegepant HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zavegepant HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zavegepant HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zavegepant HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zavegepant HCl suppliers with NDC on PharmaCompass.
Zavegepant HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zavegepant HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zavegepant HCl GMP manufacturer or Zavegepant HCl GMP API supplier for your needs.
A Zavegepant HCl CoA (Certificate of Analysis) is a formal document that attests to Zavegepant HCl's compliance with Zavegepant HCl specifications and serves as a tool for batch-level quality control.
Zavegepant HCl CoA mostly includes findings from lab analyses of a specific batch. For each Zavegepant HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zavegepant HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Zavegepant HCl EP), Zavegepant HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zavegepant HCl USP).